WCN25-1926 VOLUME MANAGEMENT IN NEPHROTIC SYNDROME - ROLE OF CARDIOMEMS by Swati Arora, Isabelle Ayoub, Brad Rovin

Get full text

WCN24-420 SAFETY AND EFFICACY OF ANIFROLUMAB IN IMMUNE COMPLEX AND APOL-1 ASSOCIATED LUPUS PODOCYTOPATHY by James Tumlin, Ryan Alex, Brad Rovin

Get full text

WCN24-847 SPARSENTAN VS IRBESARTAN IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN): SUBGROUP ANALYSES OF 2-YEAR RESULTS FROM THE PIVOTAL PHASE 3 PROTECT TRIAL by Jonathan Barratt, Brad Rovin, Edward Murphy, Radko Komers, Hernán Trimarchi, Vlado Perkovic

Get full text

WCN24-912 IMAGINATION: A GLOBAL PHASE 3 TRIAL OF RO7434656, AN ANTISENSE OLIGONUCLEOTIDE INHIBITOR OF COMPLEMENT FACTOR B, IN IGA NEPHROPATHY by Jonathan Barratt, Jürgen Flöge, Vishal Duggal, Nadine Schmit, Ji Cheng, Jeannette Lo, Brad Rovin

Get full text

WCN25-1898 IMPLICATIONS OF PROTEINURIA REMISSION ON ESTIMATED GLOMERULAR FILTRATION RATE (eGFR) TRAJECTORY IN PATIENTS (Pts) WITH IgA NEPHROPATHY (IgAN) IN PROTECT by Bruce Hendry, Hiddo JL Heerspink, Vladimir Tesar, Radko Komers, Priscila Preciado, Edward Murphy, Brad Rovin

Get full text

Bath Salts: A Newly Recognized Cause of Acute Kidney Injury by Jonathan McNeely, Samir Parikh, Christopher Valentine, Nabil Haddad, Ganesh Shidham, Brad Rovin, Lee Hebert, Anil Agarwal

Get full text

WCN24-2425 THE CHRONICITY INDEX FOR LN BIOPSIES SHOULD BE MODIFIED TO EXCLUDE FIBROUS CRESCENTS? by Valeria Alberton, Ana Malvar, Bruno Lococo, Martinez Joaquin, Sanchez Monica, Chidid Ignacio, Flores Andrea, Loor Alfredo, Brad Rovin

Get full text

Can Antinuclear Antibodies (ANA) be Monoclonal? by Laura Biederman, Anjali A. Satoskar, Mohankumar Doraiswamy, Samir Parikh, Brad Rovin, Brian Mussio, Galina Mikhalina, Sergey V. Brodsky

Get full text

WCN25-843 FELZARTAMAB REDUCES aPLA2R Ab BY SELECTIVELY DEPLETING CD38+ PLASMA CELLS AND PLASMABLASTS, THE MAIN PATHOGENIC CELLULAR DRIVERS OF DISEASE IN PRIMARY MEMBRANOUS NEPHROPA... by Donna Flesher, Rainer Boxhammer, Tabea Kräft, Millie Shah, Lisa Kivman, Stefan Härtle, Jaideep Dudani, Houston Gilbert, Uptal Patel, Brad Rovin

Get full text

Outcome of participants with nephrotic syndrome in combined clinical trials of lupus nephritis by Brad Rovin, Maria Dall’Era, Paul Brunetta, Liliana Michelle Gomez Mendez, Matthew D Cascino, Tamiko R Katsumoto, Paul Brakeman, Jay Garg

Get full text

Targeting the Type I Interferon Pathway in Glomerular Kidney Disease: Rationale and Therapeutic Opportunities by James Tumlin, Brad Rovin, Hans-Joachim Anders, Eduardo F. Mysler, David R.W. Jayne, Tsutomu Takeuchi, Catharina Lindholm, Gudrun Weiss, Alessandro Sorrentino, Kevin Woollard, Nicola Ferrari

Get full text

WCN24-762 UPDATED RESULTS FROM THE RUBY-3 STUDY OF POVETACICEPT, AN ENHANCED DUAL BAFF/APRIL ANTAGONIST, IN AUTOANTIBODY-ASSOCIATED GLOMERULONEPHRITIS by James Tumlin, Sreedhar Mandayam, Arvind Madan, Frank Cortazar, Sang-Woong Han, Hemant Kulkarni, Jonathan Barratt, Brad Rovin, Hong Zhang, Rupert Davies, Amanda Enstrom, Heather Thomas, Jiahua Li, Stanford L. Peng, Harmeet Singh

Get full text

WCN24-756 POVETACICEPT, AN ENHANCED DUAL BAFF/APRIL ANTAGONIST, IN AUTOANTIBODY-ASSOCIATED GLOMERULONEPHRITIS by James Tumlin, Sreedhar Mandayam, Arvind Madan, Frank Cortazar, Sang-Woong Han, Hemant Kulkarni, Jonathan Barratt, Brad Rovin, Hong Zhang, Rupert Davies, Amanda Enstrom, Heather Thomas, Jiahua Li, Stanford L. Peng, Harmeet Singh

Get full text

WCN25-3676 RESULTS FROM THE REGENCY TRIAL ASSESSING EFFICACY AND SAFETY OF OBINUTUZUMAB IN ACTIVE LUPUS NEPHRITIS by Brad Rovin, Richard Furie, Jay Garg, Mittermanyer Santiago, Gustavo Aroca-Martinez, Adolfina Elizabeth Zuta Santillan, Harini Raghu, Imran Hassan, Bongin Yoo, Elsa Martins, Himanshi Sehgal, Theodore Omachi, Thomas Schindler, William Pendergraft, Ana Malvar

Get full text

Global consensus building and prioritisation of fundamental lupus challenges: the ALPHA project by Victoria P Werth, Brad Rovin, Susan Manzi, Ian Bruce, Karen Costenbader, Leslie Hanrahan, Sandra Raymond, Sang-Cheol Bae, Thomas Dörner, Karin Tse, Laura Eve Schanberg, Yaritza Peña, Annick Anderson, Kathleen Arntsen, Kenneth Getz, Amy Kao, Eric Morand, Joan M Von Feldt

Get full text

Focal Segmental Glomerulosclerosis Patient Baseline Characteristics in the Sparsentan Phase 3 DUPLEX Study by Howard Trachtman, Jai Radhakrishnan, Michelle N. Rheault, Charles E. Alpers, Jonathan Barratt, Hiddo J.L. Heerspink, Irene L. Noronha, Vlado Perkovic, Brad Rovin, Hernán Trimarchi, Muh Geot Wong, Alex Mercer, Jula Inrig, William Rote, Ed Murphy, Patricia W. Bedard, Sandra Roth, Stewart Bieler, Radko Komers

Get full text